O-4 IMPACT OF BRIDGE THERAPY FOR HEPATOCELLULAR CARCINOMA IN PATIENTS SUBMITTED TO LIVER TRANSPLANTATION - BRAZILIAN MULTICENTER STUDY

Background: Hepatocellular carcinoma (HCC) is one of the main indications for liver transplantation (LT). Bridge therapy (BT) is recommended when waiting time on transplant list is longer than six months to avoid tumor progression and dropout. Response to locoregional treatment has been considered a...

Full description

Bibliographic Details
Main Authors: Julia Fadini Margon, Aline Lopes Chagas, Angelo A. Mattos, Márcio Augusto Diniz, Guilherme Eduardo Gonçalves Felga, Ilka de Fátima Santana Ferreira Boin, Rita de Cássia Martins Alves da Silva, Renato Ferreira da Silva, José Huygens Parente Garcia, Agnaldo Soares Lima, Júlio Cezar Uili Coelho, Paulo Lisboa Bittencourt, Venâncio Avancini Ferreira Alves, Luiz Augusto Carneiro D'Albuquerque, Flair José Carrilho
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268121001903